Skip to content

XLO - Xilio Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchX

Xilio Development Inc

XLO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

X

XLOXilio Development Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $12.74
52-wk low: $6.47
Prev close: $9.71
Mkt cap: $61.9M
Beta: -0.12
P/S: 1.0x

Smart money

7 funds hold a position.

Real smart money

Funds holding this stock

7 holders

Combined position$1.5M

JS
Jim Simons
Q2 2026 13F
$615K
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported May 12, 2026

Earnings came in 11.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -34.1%
Market cap: $62M

Valuation

P/S0.97
P/B0.86

Quality

Operating margin-18.7%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: XLO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $61.92M
Beta: -0.12

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.9x

Profit margin

-34.1%

Op margin

-18.7%

ROE

-55.0%

$249K

position

TS

Two Sigma

Q2 2026 13F

$139K

position

4 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 4 holders

Coverage gaps for XLO

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.58+11.7%

-$0.66 expected

Next report

What the street expects next

EPS expected

-$0.82

-$0.82 to -$0.82

Revenue expected

$4.8M

1 analysts

Estimate drift

+0.10

Change in 30 days

-55.0%

ROA-13.6%

Growth

Beta-0.12